Literature DB >> 30219265

Bowel Biofilms: Tipping Points between a Healthy and Compromised Gut?

Hanne L P Tytgat1, Franklin L Nobrega2, John van der Oost3, Willem M de Vos4.   

Abstract

Bacterial communities are known to impact human health and disease. Mixed species biofilms, mostly pathogenic in nature, have been observed in dental and gastric infections as well as in intestinal diseases, chronic gut wounds and colon cancer. Apart from the appendix, the presence of thick polymicrobial biofilms in the healthy gut mucosa is still debated. Polymicrobial biofilms containing potential pathogens appear to be an early-warning signal of developing disease and can be regarded as a tipping point between a healthy and a diseased state of the gut mucosa. Key biofilm-forming pathogens and associated molecules hold promise as biomarkers. Criteria to distinguish microcolonies from biofilms are crucial to provide clarity when reporting biofilm-related phenomena in health and disease in the gut.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  biofilm; colorectal cancer; microbiota; tipping points

Mesh:

Substances:

Year:  2018        PMID: 30219265     DOI: 10.1016/j.tim.2018.08.009

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  30 in total

Review 1.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

2.  Interactions of commensal and pathogenic microorganisms with the mucus layer in the colon.

Authors:  Rui Cai; Chen Cheng; Jianwei Chen; Xiaoqiang Xu; Chao Ding; Bing Gu
Journal:  Gut Microbes       Date:  2020-03-29

3.  Biophysical determinants of biofilm formation in the gut.

Authors:  Sandra L Arias; Ilana L Brito
Journal:  Curr Opin Biomed Eng       Date:  2021-02-13

4.  Klebsiella pneumoniae l-Fucose Metabolism Promotes Gastrointestinal Colonization and Modulates Its Virulence Determinants.

Authors:  Andrew W Hudson; Andrew J Barnes; Andrew S Bray; David A Ornelles; M Ammar Zafar
Journal:  Infect Immun       Date:  2022-09-21       Impact factor: 3.609

Review 5.  Escherichia coli Residency in the Gut of Healthy Human Adults.

Authors:  Jonathan N V Martinson; Seth T Walk
Journal:  EcoSal Plus       Date:  2020-09

Review 6.  Gastrointestinal biofilms in health and disease.

Authors:  Jean-Paul Motta; John L Wallace; André G Buret; Céline Deraison; Nathalie Vergnolle
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-01-28       Impact factor: 46.802

Review 7.  Host responses to mucosal biofilms in the lung and gut.

Authors:  Jada C Domingue; Julia L Drewes; Christian A Merlo; Franck Housseau; Cynthia L Sears
Journal:  Mucosal Immunol       Date:  2020-02-28       Impact factor: 7.313

Review 8.  The Human Gut Phageome: Origins and Roles in the Human Gut Microbiome.

Authors:  Eleanor M Townsend; Lucy Kelly; George Muscatt; Joshua D Box; Nicole Hargraves; Daniel Lilley; Eleanor Jameson
Journal:  Front Cell Infect Microbiol       Date:  2021-06-04       Impact factor: 5.293

9.  Prediction of Minocycline Activity in the Gut From a Pig Preclinical Model Using a Pharmacokinetic -Pharmacodynamic Approach.

Authors:  Quentin Vallé; Béatrice B Roques; Alain Bousquet-Mélou; David Dahlhaus; Felipe Ramon-Portugal; Véronique Dupouy; Delphine Bibbal; Aude A Ferran
Journal:  Front Microbiol       Date:  2021-07-09       Impact factor: 5.640

10.  Architecture of cell-cell junctions in situ reveals a mechanism for bacterial biofilm inhibition.

Authors:  Charlotte E Melia; Jani R Bolla; Stefan Katharios-Lanwermeyer; Daniel B Mihaylov; Patrick C Hoffmann; Jiandong Huo; Michael R Wozny; Louis M Elfari; Jan Böhning; Ashleigh N Morgan; Charlie J Hitchman; Raymond J Owens; Carol V Robinson; George A O'Toole; Tanmay A M Bharat
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.